Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sutro Biopharma Inc

0.8101
-0.4399-35.19%
Post-market: 0.8100-0.0001-0.01%19:59 EDT
Volume:15.13M
Turnover:13.30M
Market Cap:66.80M
PE:-0.47
High:1.01
Open:0.9990
Low:0.8084
Close:1.25
Loading ...

Sutro Biopharma Inc (STRO) Q4 2024 Earnings Call Highlights: Strategic Focus and Financial ...

GuruFocus.com
·
10 hours ago

Sutro Biopharma Cut to Market Perform From Market Outperform by Citizens Capital Markets

Dow Jones
·
Yesterday

Nasdaq Surges 1.5%; Ulta Beauty Posts Upbeat Results

Benzinga
·
Yesterday

Piper Sandler Downgrades Sutro Biopharma to Neutral From Overweight, Adjusts PT to $2 From $8

MT Newswires Live
·
Yesterday

Sutro Biopharma Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $2 From $8

THOMSON REUTERS
·
Yesterday

Sutro Biopharma Falls as Company Cuts Workforce, Shifts Focus to ADCs

GuruFocus.com
·
Yesterday

Truist Financial Reaffirms Their Buy Rating on Sutro Biopharma (STRO)

TIPRANKS
·
Yesterday

Sutro Biopharma Inc : Wedbush Cuts to Neutral From Outperform; Cuts Target Price to $2 From $8

THOMSON REUTERS
·
Yesterday

Sutro Biopharma Cut to Underperform From Buy by B of A Securities

Dow Jones
·
Yesterday

Truist Removes $15 Price Target From Sutro Biopharma, Keeps Buy Rating

MT Newswires Live
·
Yesterday

Sutro Biopharma downgraded to Underperform from Buy at BofA

TIPRANKS
·
Yesterday

Sutro Biopharma Names New CEO; Plans to Reduce Workforce by Nearly 50% After Portfolio Review

MT Newswires Live
·
Yesterday

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sutro Biopharma (STRO) and Generation Bio (GBIO)

TIPRANKS
·
Yesterday

Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
Yesterday

Sutro Biopharma Review Results in 50% Workforce Reduction, CEO Transition

Dow Jones
·
Yesterday

Sutro Biopharma FY 2024 GAAP EPS $(2.96) Misses $(2.92) Estimate, Sales $62.043M Beat $59.004M Estimate

Benzinga
·
Yesterday